Incorporating HIV/HCV Prevention, Screening, and Linkage to Care Into Opioid Use Disorder Treatment Settings

In this downloadable slideset, CCO’s expert faculty reviews important strategies for expanding addiction medicine services to include prevention, screening, diagnosis, and linkage to HCV and HIV care for patients with opioid use disorder.
Alain H. Litwin, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.42 MB
Released: September 18, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
American Society of Addiction Medicine
Educational grant provided by:
Gilead Sciences

Related Content

CCO commentary by Jennifer Cocohoba, PharmD, on how to avoid polypharmacy in aging patients with HIV

Jennifer Cocohoba Headshot Jennifer Cocohoba, PharmD Released: October 12, 2020

CCO slides on ending the HIV epidemic in the United States via expanded testing, enhanced linkage to care, and rapid response to potential outbreaks

Lisa K. Fitzpatrick, MD, MPH, MPA David Malebranche, MD, MPH Released: October 7, 2020

Downloadable PDF resource from CCO on HCV and HIV screening essentials and HIV PrEP basics for addiction medicine specialists

Andrew Seaman, MD Released: October 2, 2020

Expert-authored CCO slides on current and future HIV prevention strategies, including FTC/TDF and FTC/TAF PrEP and long-acting injectable PrEP

W. David Hardy, MD
Program Director
Gregory Huhn, MD, MPHTM
Released: September 25, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue